Antiviral drugs in the immunocompetent host: Part I. Treatment of hepatitis, cytomegalovirus, and herpes infections

American Family Physician

Volumn 67, Issue 4, 2003, Pages 757-762

  Colgan, Richard ^a   Michocki, Robert ^b   Greisman, Lisa ^c   Moore, Tracy A Wolff ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ADEFOVIR DIPIVOXIL; ANTIVIRUS AGENT; BEHENYL ALCOHOL; FAMCICLOVIR; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; LAMIVUDINE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PENCICLOVIR; REBETRON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; SYTOVENE; UNCLASSIFIED DRUG; VALACICLOVIR;

ACUTE KIDNEY FAILURE; ANEMIA; AUTOIMMUNE DISEASE; BONE MARROW SUPPRESSION; CHICKENPOX; CLINICAL TRIAL; COUGHING; CYTOMEGALOVIRUS INFECTION; DEPRESSION; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DRUG CHOICE; DRUG COST; ELECTROLYTE DISTURBANCE; FATIGUE; FEVER; FLU LIKE SYNDROME; HEADACHE; HEALTH CARE COST; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HERPES; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOCOMPETENCE; KIDNEY FAILURE; LEUKOPENIA; LIVER DYSFUNCTION; MYALGIA; NAUSEA; NEUROTOXICITY; PAIN; PARESTHESIA; POSTHERPETIC NEURALGIA; PRURITUS; RASH; RECURRENT INFECTION; RETINOPATHY; REVIEW; SIDE EFFECT; SKIN IRRITATION; THROMBOCYTOPENIA; TINNITUS; TREATMENT INDICATION; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VERTIGO; VOMITING; WEIGHT REDUCTION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNOCOMPETENCE;

EID: 0346212547     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422-7.
2. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-63.
3. Perrillo R, Schiff E, Yoshida E, Statler A, Hirsch K, Wright T, et al. Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology 2000;32:129-34.
4. Yang H, Westland CE, Delaney WE 4th, Heathcote EJ, Ho V, Fry J, et al. Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks. Hepatology 2002;36:464-73.
5. Lauer GM, Waler BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
6. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-82.
7. Manns MP, McHutchinson JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958-65.
8. Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452-7.
9. Terrault NA. Chronic hepatitis B. Curr Treat Options Gastroenterol 2001;4:493-502.
10. Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 1997;24:52-6.
11. Physicians' desk reference. Accessed November 2002 at: www.pdr.net (with password).
12. Kaplowitz LG, Baker D, Gelb L, Blythe J, Hale R, Frost P, et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. The Acyclovir Study Group. JAMA 1991;265:747-51.
13. Mertz G, Jones CC, Mills J, Fife KH, Lemon SM, Stapleton JT, et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multi-center double-blind trial. JAMA 1988;260:201-6.
14. Baker DA, Blythe JG, Miller JM. Once-daily valacyclovir hydrochloride for suppression of recurrent genital herpes. Obstet Gynecol 1999;94:103-6.
15. Reitano M, Tyring S, Lang W, Thoming C, Worm GM, Borelli S, et al. Valacyclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valacyclovir HSV Study Group. J Infect Dis 1998;178:603-10.
16. Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner K. A large-scale, placebo-controlled, doseranging trial of peroral valacyclovir for episodic treatment of recurrent herpes genitalis. Valacyclovir HSV Study Group. Arch Intern Med 1996;156:1729-35.
17. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multi-center trial. Canadian Famciclovir Study Group. JAMA 1996;276:44-9.
18. Diaz-Mitoma F, Sibbald G, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA 1998;280:887-92.
19. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet 2001;357:1513-8.
20. Amir J, Harel L, Smetana Z, Varsano I. Treatment of herpes simplex gingivostomatitis with acyclovir in children. A randomised, double-blind, placebo-controlled study. BMJ 1997;314:1800-3.
21. Spruance SL, Rowe NH, Raborn W, Thibodeau EA, D'Ambosio JA, Bernstein DI. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. J Infect Dis 1999;179:303-10.
22. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R. Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA 1997;277:1374-9.
23. Sacks SL, Thisted RA, Jones TM, Barbarash RA, Mikolich DJ, Ruoff GE, et al. Clinical efficacy of topical docosanol 10 percent cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol 2001;45:222-30.
24. Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988;85 (suppl 2A):79-83.
25. Drugs for non-HIV viral infections. Med Lett Drugs Ther 1999;41:113-20.
26. Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, et al. Famciclovir for the treatment of acute herpes zoster: effects of acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995;123:89-96.
27. Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000;9:863-9.